BindingDB logo
myBDB logout

null

SMILES: CC#CCn1c(N[C@@H](C)c2ccc(cc2)C(F)(F)F)nc2CCN(Cc2c1=O)C(=O)c1ccc2NC(=O)CCc2c1

InChI Key: InChIKey=RJUYGBKLPBHDEW-SFHVURJKSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 195650   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Prolactin-releasing peptide receptor


(Homo sapiens (Human))
BDBM195650
PNG
(US9206173, 2412)
Show SMILES CC#CCn1c(N[C@@H](C)c2ccc(cc2)C(F)(F)F)nc2CCN(Cc2c1=O)C(=O)c1ccc2NC(=O)CCc2c1 |r|
Show InChI InChI=1S/C30H28F3N5O3/c1-3-4-14-38-28(41)23-17-37(27(40)21-7-11-24-20(16-21)8-12-26(39)35-24)15-13-25(23)36-29(38)34-18(2)19-5-9-22(10-6-19)30(31,32)33/h5-7,9-11,16,18H,8,12-15,17H2,1-2H3,(H,34,36)(H,35,39)/t18-/m0/s1
UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
8 -11.0n/an/an/an/an/a7.425



OTSUKA PHARMACEUTICAL CO., LTD.

US Patent


Assay Description
Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...


US Patent US9206173 (2015)


BindingDB Entry DOI: 10.7270/Q23X85FS
More data for this
Ligand-Target Pair
Prolactin-releasing peptide receptor


(Homo sapiens (Human))
BDBM195650
PNG
(US9206173, 2412)
Show SMILES CC#CCn1c(N[C@@H](C)c2ccc(cc2)C(F)(F)F)nc2CCN(Cc2c1=O)C(=O)c1ccc2NC(=O)CCc2c1 |r|
Show InChI InChI=1S/C30H28F3N5O3/c1-3-4-14-38-28(41)23-17-37(27(40)21-7-11-24-20(16-21)8-12-26(39)35-24)15-13-25(23)36-29(38)34-18(2)19-5-9-22(10-6-19)30(31,32)33/h5-7,9-11,16,18H,8,12-15,17H2,1-2H3,(H,34,36)(H,35,39)/t18-/m0/s1
UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 259n/an/an/an/a7.425



OTSUKA PHARMACEUTICAL CO., LTD.

US Patent


Assay Description
HEK293 cells expressing human GPR10 were maintained in Dulbecco's Modified Eagles' medium supplemented with 10% fetal bovine serum, 1% penici...


US Patent US9206173 (2015)


BindingDB Entry DOI: 10.7270/Q23X85FS
More data for this
Ligand-Target Pair